Medical professionals must take into consideration regardless of whether their sufferers with underlying NAION hazard elements could possibly be adversely influenced by usage of PDE5 inhibitors. Individuals who have already seasoned NAION are at improved risk of NAION recurrence. Thus, PDE5 inhibitors, like LEVITRA, should be utilized with caution